Compugen Ltd.

NASDAQ:CGEN

Biotechnology

Healthcare
$1.96 +0.50%

+$0.01 today

Market cap
$185.66M
Beta
2.74
P/E (TTM)
5.4
EPS (TTM)
$0.37
52W Low $1.30High $3.24

Volume 0.15M

Average 0.48M

CGEN Total Current Assets

All assets expected to be converted to cash or used up within one year.

Compugen Ltd.NASDAQ: CGEN

Total Current Assets · Q1 FY2026 · quarter ended Mar 2026

Total current assets rises 28.4% from a year ago

Total current assets stood at $137.28M at the end of Q1 FY2026, up 28.4% from a year earlier and down 7.3% from the prior quarter. Over 3 fiscal years it compounded at +19.8% a year.

Context

  • Total current assets amounted to 94.1% of total assets at the end of Q1 FY2026, up 1.5 pp from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total current assets keeps rising in the next quarterly balance sheet after a +28.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$137.28M-7.3% QoQ
Last fiscal yearDec 2025
$148.02M+39.6% YoY
Year agoMar 2025
$106.89M+28.4% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+28.4%——
1 year+39.6%——
3-year CAGR+19.8%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
148.02M USD
Year-over-year change
+39.6%
4-year CAGR
+4.7%

Total Current Assets vs competitors

How CGEN compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +28.4% is the 4th highest of 9, against a peer median of -5.6%.
  • Total current assets amounts to 94.1% of total assets for CGEN, versus a peer median of 95.4%.
CGEN Competitors
Total Current Assets for CGEN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TNXPTonix Pharmaceuticals Holding Corp.Mar 2026$207.17M USD+38.5%+20.5%80.3%
MISTMilestone Pharmaceuticals Inc.Mar 2026$192.25M USD+217.9%+15.9%99.2%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$143.57M USD+4.5%+40.5%99.4%
CGENCompugen Ltd.Mar 2026$137.28M USD+28.4%+19.8%94.1%
MOLNMolecular Partners AGMar 2026CHF 82.68M CHF-39.6%-27.6%94.6%
CRDFCardiff Oncology, Inc.Mar 2026$47.34M USD-42.8%-18.6%96.3%
RANIRani Therapeutics Holdings, Inc.Mar 2026$47.09M USD+164.8%-19.2%90.8%
IPHAInnate Pharma S.A.Dec 2025€46.69M EUR-45.5%-30.6%74.5%
NVCTNuvectis Pharma, Inc.Mar 2026$25.4M USD-15.8%+15.8%100.0%
Peer median (excluding CGEN) —-5.6%-1.4%95.4%

Competitors are the stored peer set for CGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents7.8M11.06M13.89M18.23M90.6M
Short-term Investments109.25M72.29M36.8M85.03M55.04M
Net Receivables188K317K61.32M269K294K
Inventory00000
Other Current Assets713K362K365K00
Total Current Assets123.22M86.13M114.58M106M148.02M
Property, Plant & Equipment (Net)3.91M3.36M2.55M3.7M3.2M
Goodwill00000
Intangible Assets00000
Long-term Investments0000410K
Tax Assets0000303K
Other Non-current Assets5.04M4.69M4.21M5.3M4.94M
Total Non-current Assets8.94M8.05M6.76M9M8.85M
Total Assets132.16M94.18M121.33M115M156.87M
Account Payables4.62M1.77M3.5M1.84M2.35M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0011.15M9.63M10.97M
Other Current Liabilities6.93M3.14M3.13M3.07M3.05M
Total Current Liabilities17.1M11.92M26.27M20.16M22.57M
Long-term Debt00000
Deferred Tax Liabilities0000303K
Deferred Revenue (Non-current)0025.39M34.05M24.94M
Other Non-current Liabilities6.39M3.27M3.4M3.41M3.89M
Total Non-current Liabilities8.37M4.58M29.51M39.92M31.57M
Total Liabilities25.47M16.5M55.78M60.08M54.14M
Common Stock239K240K247K248K262K
Retained Earnings(422.08M)(455.77M)(474.53M)(488.76M)(453.42M)
Accumulated OCI002K11K8K
Other Stockholders Equity00000
Minority Interest00000
Total Equity106.69M77.68M65.56M54.91M102.73M
Total Debt2.75M1.93M1.35M2.91M2.96M
Net Debt(5.05M)(9.13M)(12.54M)(15.32M)(87.64M)

Compugen Ltd.

NASDAQ:CGEN

Intrinsic Alpha fair value

Locked

Current Price

$1.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.